Common coltsfoot flower, dwarf lilyturf tuber, white mulberry root-bark, ginkgo seed, whiteflower hogfennel root, elaeagnus pungens and Chinese wolfberry root-bark decoction for treating bronchial asthma

Abstract

The invention relates to the field of medicine formulas, in particular to common coltsfoot flower, dwarf lilyturf tuber, white mulberry root-bark, ginkgo seed, whiteflower hogfennel root, elaeagnus pungens and Chinese wolfberry root-bark decoction for treating bronchial asthma. The decoction is prepared by soaking Chinese herbal medicines such as 4 to 8 weight percent of common coltsfoot flower, 5 to 8 weight percent of dwarf lilyturf tuber, 5 to 8 weight percent of white mulberry root-bark, 3 to 6 weight percent of ginkgo seed, 5 to 8 weight percent of whiteflower hogfennel root, 4 to 7 weight percent of elaeagnus pungens, 6 to 9 weight percent of Chinese wolfberry root-bark, 6 to 9 weight percent of root of red-rooted salvia, 4 to 6 weight percent of great burdock achene, 5 to 7 weight percent of paniculate swallowwort root, 5 to 7 weight percent of tuckahoe, 3 to 5 weight percent of fineleaf schizonepeta herb, 3 to 5 weight percent of perilla fruit, 2 to 5 weight percent of pinellia tuber, 3 to 6 weight percent of tangerine peel, 2 to 5 weight percent of roasted liquoric root, 3 to 5 weight percent of honeysuckle flower and 5 to 8 weight percent of common anemarrhena rhizome inwater, decocting, deslagging to form filtrate. The decoction is low in cost, has a high effect of treating bronchial asthma, does not have any toxic or side effect, has the effects of clearing lung, eliminating phlegm, promoting expectoration, relieving asthma and ventilating lung, and is suitable for asthenia and sthenia syndromes of asthma.

Description

technical field [0001] The invention relates to a Chinese patent medicine preparation, in particular to a Dongbaihugu decoction used for bronchial asthma. Background technique [0002] As we all know, bronchial asthma is a common and frequently-occurring disease of the respiratory system, and is a chronic inflammatory disease of the airway involving a variety of cells and cellular components. This chronic inflammation is associated with airway hyperresponsiveness, causing spastic constriction of bronchial smooth muscle, vasodilation, mucosal edema, and increased secretion, leading to a disease of reversible airway obstruction. The main clinical manifestations are episodic dyspnea accompanied by wheezing, cough and sputum, often exacerbated at night and in the early morning. If bronchial asthma is not diagnosed and treated in time, it can cause irreversible airway constriction and airway remodeling with the prolongation of the course of the disease. In severe cases, it is fo...

AI Technical Summary

Problems solved by technology

At present, clinical treatment is mainly controlled by hormones and other methods, which is not only expensive, but also easy to relapse, which brings great economic and mental burden to patients.

Images